Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
about
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Pembrolizumab in Treating Youn ...... Ependymoma or Medulloblastoma
@en
type
label
Pembrolizumab in Treating Youn ...... Ependymoma or Medulloblastoma
@en
prefLabel
Pembrolizumab in Treating Youn ...... Ependymoma or Medulloblastoma
@en
P1050
P1476
A Safety and Preliminary Effic ...... a or Hypermutated Brain Tumors
@en
P3098
NCT02359565
P4844
P580
2015-05-22T00:00:00Z
P582
2020-04-01T00:00:00Z